Methods of screening for antagonists of apm1/gzip
CA 2461491 A1 · Owner: Guerassimenko, Oxana · Inventors: Guerassimenko, Oxana; Chumakov, Ilya
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to the field of metabolic research. Metabolic disorders, such as besity, are a public health problem that is serious and widespread. GZIP polypeptides have been identified that are believed to be beneficial in the treatment of metabolic disorders. These compounds should be effective for reducing body mass and for treating metabolic-related diseases and disorders. These metabolic-related diseases and disorders include hyperlipidemias, atherosclerosis, diabetes and hypertension.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 3, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 3, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 3, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.